SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Plasma-derived medicinal products self-sufficiency from national plasma: to what extent?
6 references·1 citing·19 second hop
Plasma-derived medicinal products self-sufficiency from national plasma: to what extent? (2013)Plasma-derived medicinal products self-su…Sustainability of a public system for plasma collection, contract fractionation and plasma-derived medicinal product manufacturing. (2013)Sustainability of a public sy…Is self-sufficiency in haemotherapies a practical or necessary goal? (2013)Is self-sufficiency in haemot…Expert Consensus Statement on achieving self‐sufficiency in safe blood and blood products, based on voluntary non‐remunerated blood donation (VNRBD)* (2012)Expert Consensus Statement on…The Dublin Consensus Statement 2011 on vital issues relating to the collection and provision of blood components and plasma‐derived medicinal products (2011)The Dublin Consensus Statemen…Best practices in regulation of blood and blood products (2011)Best practices in regulation …Fractionnement plasmatique international : état des lieux (2007)Fractionnement plasmatique in…Trends in Plasma Toll Fractionation for Self Sufficiency of Plasma-Derived Medicinal Products in Italy (2019)Trends in Plasma Toll Fractio…Reducing the risk of infection from plasma products: specific preventative strategies (2000)Intravenous immunoglobulin: regulatory perspectives on use and supply (2001)Economical impact of plasma fractionation project in Iran on affordability of plasma‐derived medicines (2009)HIV and the blood supply: an analysis of crisis decision making. (1996)Safety of the Blood Supply in the United States: Opportunities and Controversies (1997)Risk Analysis: A Quantitative Guide (2000)Blood Bank Regulations in India (2012)Implementation and performance of haemovigilance systems in 10 sub-saharan African countries is sub-optimal (2021)Implications of demographics on future blood supply: a population‐based cross‐sectional study (2010)Toward a patient-based paradigm for blood transfusion (2014)Silenced uses and moral ideals in the exchange of Danish blood and plasma (2015)The European Commission (2015)Paying for Plasma: Commodification, Exploitation, and Canada's Plasma Shortage (2019)The Dublin Consensus Statement on vital issues relating to the collection of blood and plasma and the manufacture of plasma products (2010)Production of plasma-derived medicinal products: ethical implications for blood donation and donors. (2014)Towards 100% voluntary blood donation: a global framework for action. (2010)Why Do Blood Donors Lapse or Reduce Their Donation's Frequency? (2015)A systematic review of incentives in blood donation (2017)Challenges for Plasma-Derived Medicinal Products (2023)
this work references cited by second hop

References

  • 2012Expert Consensus Statement on achieving self‐sufficiency in safe blood and blood products, based on voluntary non‐remunerated blood donation (VNRBD)*125 cited
  • 2007Fractionnement plasmatique international : état des lieux22 cited
  • 2011Best practices in regulation of blood and blood products19 cited
  • 2011The Dublin Consensus Statement 2011 on vital issues relating to the collection and provision of blood components and plasma‐derived medicinal products17 cited
  • 2013Is self-sufficiency in haemotherapies a practical or necessary goal?14 cited
  • 2013Sustainability of a public system for plasma collection, contract fractionation and plasma-derived medicinal product manufacturing.13 cited

Cited by

  • 2019Trends in Plasma Toll Fractionation for Self Sufficiency of Plasma-Derived Medicinal Products in Italy9 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work